Addressing mast cells and the sympathetic system

Could peptides be the key to restarting stalled healing? In this episode of Peptides & Longevity, Dr. Eric Gordon shares a paradigm-shifting perspective on chronic illness through the lens of metabolomics, mitochondrial function, and the cell danger response. He reveals how chronic conditions are less about broken systems and more about misfiring healing cycles—and where peptides may help guide recovery.

In this episode of Peptides & Longevity, Dr. Eric Gordon unpacks decades of insight into the root mechanisms behind chronic illness. He introduces listeners to metabolomics—a scientific field that tracks thousands of small molecules in the body to reveal hidden dysfunctions in metabolism, inflammation, and mitochondrial signaling. Dr. Gordon explains how chronic fatigue syndrome and other illnesses may stem from a prolonged ‘cell danger response,’ where the body gets trapped in a state of protective shutdown, despite the original threat having passed.

Dr. Gordon discusses the implications of this model on diagnosis and treatment. Standard labs often fail to capture these dynamics, leading to misdiagnosis or dismissal of real suffering. Instead, he advocates for understanding the cell’s healing phases, especially the role mitochondria play not just in energy production, but in immune communication. He also touches on the powerful potential of peptides like BPC-157 and thymosins, which can nudge the body out of chronic inflammation and support more complete healing. This conversation reframes chronic illness from a frustrating mystery into a process we can finally begin to understand—and influence.
Dr. Eric Gordon is a pioneering integrative physician with over four decades of clinical experience specializing in complex chronic illness. As the founder of Gordon Medical Associates and president of the Gordon Medical Research Center in the San Francisco Bay Area, he has dedicated his career to helping patients who often fall through the cracks of conventional medicine—those with chronic fatigue syndrome, Lyme disease, fibromyalgia, mast cell activation, and autoimmune conditions.

A passionate collaborator and educator, Dr. Gordon co-authored the groundbreaking study ‘Metabolic Features of Chronic Fatigue Syndrome’ published in the Proceedings of the National Academy of Sciences. This work introduced the revolutionary concept of the cell danger response, a framework that redefines chronic illness as a stuck healing process rather than ongoing damage. Today, Dr. Gordon continues to explore how metabolomics, mitochondrial health, and peptides intersect to reshape diagnosis and treatment in chronic disease. His work bridges research and real-world care, empowering both practitioners and patients to think differently and act more effectively.

----

Dr. Eric Gordon

Website: https://www.gordonmedical.com/  

Instagram: https://www.instagram.com/gordonmedical/ 

LinkedIn: https://www.linkedin.com/in/eric-gordon-2329ba30/ 

Facebook: https://www.facebook.com/gordonmedical

----

Integrative Peptides

Website: https://integrativepeptides.com/

Facebook: https://www.facebook.com/integrativepeptidesofficial/

Instagram: https://www.instagram.com/integrativepeptides/

----

Holtorf Medical Group

Website: https://holtorfmed.com/

Facebook: https://www.facebook.com/holtorfmed/

Instagram: https://www.instagram.com/holtorfmedicalgroup/

----

Kent Holtorf, MD

YouTube: https://www.youtube.com/channel/UC0S6Kaa1V9-dfo2sPyZPT6A

----

Produced by DrTalks  https://drtalks.com/podcast-service/